Stifel Financial’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Stifel Financial’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-13,500	Closed	-$23K	–	2878
2018 Q3	$23K	Hold	13,500	–	–	﹤0.01%	2730
2018 Q2	$23K	Hold	13,500	–	–	﹤0.01%	2686
2018 Q1	$23K	Buy	+13,500	New	+$28.5K	﹤0.01%	2667
2017 Q2	–	Sell	-30,289	Closed	-$144K	–	2660
2017 Q1	$144K	Buy	30,289 +7,750	+34%	+$44.9K	﹤0.01%	2382
2016 Q4	$140K	Sell	22,539 -1,389	-6%	-$7.26K	﹤0.01%	2324
2016 Q3	$129K	Sell	23,928 -544	-2%	-$2.55K	﹤0.01%	2271
2016 Q2	$93K	Buy	+24,472	New	+$82.9K	﹤0.01%	2389

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OCM

Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Stifel Financial's SGYP Position: Q4 2018 in Review

Stifel Financial sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 13,500 shares — an estimated $23K sold.

Stifel Financial first reported a position in SGYP in Q2 2016 and held it in 7 quarters. The position peaked at $144K in Q1 2017. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Stifel Financial reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Stifel Financial sold 13,500 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $23K.
Stifel Financial first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2016 and held it in 7 quarters.
Stifel Financial's Synergy Pharmaceuticals, Inc Common Stock position peaked at $144K in Q1 2017.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Stifel Financial's 13F filing for Q4 2018, filed 13 Feb 2019.